At a glance
ClinicalIndex Comparison RecordN/ACompleted· 950 enrolled
Drug / intervention
ConforMIS iUni, iDuo, or iTotal (CR)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Retrospective Study to Evaluate the ConforMIS iUni, iDuo & iTotal® CR (Cruciate Retaining) Knee Replacement Systems
In Brief
An observational study evaluating ConforMIS iUni, iDuo, or iTotal (CR) for Osteoarthritis, Knee and Knee Osteoarthritis. Completed, enrolled 950 participants across 1 site.
Detailed Summary
This study is designed to evaluate implant survivorship, patient satisfaction, and patient-reported outcomes of subjects who have undergone surgery with any of the following ConforMIS knee implants: the iUni®, iDuo® or iTotal® Cruciate Retaining (CR) Knee Replacement Systems.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee, Knee Osteoarthritis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartApr 2017
First PostedMay 2017
Primary CompletionSep 2019
Study CompletionDec 2019
TodayJul 2026
First PostedMay 15, 2017
Enrollment StartApr 1, 2017
Primary CompletionSep 1, 2019
Study CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.1 years ago
Interventions
ConforMIS iUni, iDuo, or iTotal (CR)device
ConforMIS iUni, iDuo, or iTotal (CR)